Amylyx Pharmaceuticals
AMLX
#7449
Rank
$0.30 B
Marketcap
$3.41
Share price
-1.45%
Change (1 day)
26.77%
Change (1 year)

Amylyx Pharmaceuticals (AMLX) - Cash on Hand

Cash on Hand as of December 2024 : $0.17 Billion USD

According to Amylyx Pharmaceuticals's latest financial reports the company has $0.17 Billion USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Amylyx Pharmaceuticals - Cash on Hand chart (from 2020 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31$0.17 B-52.47%
2023-12-31$0.37 B7.04%
2022-12-31$0.34 B260.96%
2021-12-31$96.11 M646.43%
2020-12-31$12.87 M320.13%
2019-12-31$3.06 M